Engineers developed techniques for growing personalized replacement facial bone from stem cells that in tests with pigs precisely fit their recipients’ faces. . . . → Read More: Engineered Facial Bone Grown from Stem Cells
|
|||||
Engineers developed techniques for growing personalized replacement facial bone from stem cells that in tests with pigs precisely fit their recipients’ faces. . . . → Read More: Engineered Facial Bone Grown from Stem Cells Ansys, a developer of engineering simulation software and services, is starting an additive manufacturing lab at University of Pittsburgh’s engineering school. . . . → Read More: Univ. of Pittsburgh, Ansys Partner on Additive Mfring 15 June 2016. A biomedical engineering team developed a chip built on graphene that detects mutations in genetic material, for eventual use in mobile diagnostics equipment. Researchers from University of California in San Diego, led . . . → Read More: Graphene Chip Detects DNA, RNA Mutations 14 June 2016. A drug to reduce glucose levels was shown in a clinical trial to reduce serious heart disease in people with type 2 diabetes also at high risk of heart disease. Results of the late-stage trial testing the drug liraglutide, marketed by drug-maker Novo Nordisk under the brand name Victoza, . . . → Read More: Glucose Drug Reduces Heart Disease in People with Diabetes 14 June 2016. A clinical trial testing a drug treating chronic cough — coughs continuing for 8 weeks or more — will begin recruiting participants in the U.K. to join other sites in the U.S. The U.K. sites are under . . . → Read More: Trial Underway Testing Drug to Reduce Chronic Cough 13 June 2016. A collaboration between businesses and universities outlined a strategy to develop processes and technologies for large-scale manufacturing of human cells for therapies and diagnostics. The National Cell Manufacturing Consortium, residing at Georgia Institute of Technology, announced . . . → Read More: Consortium Aims to Upgrade Cell Manufacturing 13 June 2016. Food and Drug Administration approved for marketing the U.S. a vaccine to prevent cholera for travelers to regions in the world where contaminated food or water is causing the disease. Vaxchora by PaxVax Inc. in Redwood City, California is . . . → Read More: FDA Approves Cholera Vaccine 10 June 2016. A biomedical engineering center at Harvard University developed a process for quickly isolating staph bacteria from clinical samples for lab testing. The team led by Donald Ingber, director of the Wyss Institute for Biologically Inspired Engineering at Harvard, published its findings earlier . . . → Read More: Process Devised to Quickly Isolate Bacteria in Lab Samples 10 June 2016. An evaluation of two new biologic drugs to treat diabetic macular edema, an eye disease caused by diabetes, show the drugs do not provide enough additional benefit over much less expensive treatments to justify their higher price tags. The team led by Adam Glassman of the Jaeb Center for . . . → Read More: New Diabetic Eye Disease Drugs Shown Not Cost-Effective 9 June 2016. A clinical center specializing in metabolic disorders is collaborating with a designer of mobile diabetes software on research to upgrade and enhance the company’s apps. Financial terms of the agreement between Profil Institute for Clinical Research in Chula Vista, California and mySugr GmbH in . . . → Read More: Clinical Center, Mobile Developer Partner on Diabetes Apps |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
You must be logged in to post a comment.